Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling

被引：19
|
作者：
Zhang, Haiyu [1 ]
Ge, Tingting [2 ]
Cui, Xiaoming [1 ]
Hou, Yan [1 ]
Ke, Chaofu [1 ]
Yang, Meng [2 ]
Yang, Kai [1 ]
Wang, Jingtao [1 ]
Guo, Bing [1 ]
Zhang, Fan [1 ]
Lou, Ge [2 ]
Li, Kang [1 ]
机构：
[1] Harbin Med Univ, Dept Epidemiol & Biostat, Harbin 150081, Peoples R China
[2] Harbin Med Univ, Dept Gynecol Oncol, Tumor Hosp, Harbin 150086, Peoples R China
来源：
MOLECULAR BIOSYSTEMS | 2015年 / 11卷 / 02期
基金：
中国国家自然科学基金; 高等学校博士学科点专项科研基金;
关键词：
CHROMATOGRAPHY-MASS-SPECTROMETRY; T-CELL PROLIFERATION; INDOLEAMINE 2,3-DIOXYGENASE; POTENTIAL BIOMARKERS; DENDRITIC CELLS; STAGE-III; TRYPTOPHAN; IDENTIFICATION; INHIBITION; LYSOPHOSPHATIDYLCHOLINE;
D O I：
10.1039/c4mb00407h
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Epithelial ovarian cancer (EOC) is the most lethal of gynecologic malignancies due to the high rate of recurrence and poor prognosis. Predicting the prognosis in patients with EOC is clinically challenging, partly because appropriate biomarkers of recurrence have yet to be explored. In this prospective study, pre-treatment plasma samples were collected from 38 patients with stage III or IV EOC who were subsequently followed up. Ultra-performance liquid chromatography mass spectrometry was used to perform metabolic profiling, which yielded five metabolites that were potential biomarkers for EOC recurrence: L-tryptophan, kynurenine, bilirubin, LysoPC (14 : 0) and LysoPE (18 : 2). A combination of these five potential biomarkers strongly predicted recurrence, the area under the curve being 0.91. In summary, the candidate biomarkers identified in this study may both facilitate clinical prediction of EOC recurrence and prognosis and serve as potential therapeutic targets in patients with EOC.
引用
收藏
页码：516 / 521
页数：6
相关论文
共 50 条
  • [31] A novel algorithm for network-based prediction of cancer recurrence
    Ruan, Jianhua
    Jahid, Md Jamiul
    Gu, Fei
    Lei, Chengwei
    Huang, Yi-Wen
    Hsu, Ya-Ting
    Mutch, David G.
    Chen, Chun-Liang
    Kirma, Nameer B.
    Huang, Tim H-M
    GENOMICS, 2019, 111 (01) : 17 - 23
  • [32] Urinary hydrophilic and hydrophobic metabolic profiling based on liquid chromatography-mass spectrometry methods: Differential metabolite discovery specific to ovarian cancer
    Chen, Jing
    Zhou, Lina
    Zhang, Xiaoyan
    Lu, Xin
    Cao, Rui
    Xu, Congjian
    Xu, Guowang
    ELECTROPHORESIS, 2012, 33 (22) : 3361 - 3369
  • [33] Olaparib and advanced ovarian cancer: Summary of the past and looking into the future
    Maiorano, Brigida Anna
    Maiorano, Mauro Francesco Pio
    Maiello, Evaristo
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [34] Pharmacokinetics of paclitaxel and carboplatin in a hemodialysis patient with advanced ovarian cancer
    Yoshida, H.
    Sumi, T.
    Abe, K.
    Ishiko, O.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2009, 30 (05) : 583 - 585
  • [35] Can lymphadenectomy be omitted in advanced ovarian cancer?-a brief review
    Salcedo-Hernandez, Rosa A.
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (04)
  • [36] Plasma metabolic profiling analysis of Cortex Periplocae-induced cardiotoxicity based on UPLC/Q-TOF-MS
    Li, Yubo
    Liu, Chuanxin
    Du, Jun
    Sheng, Xue
    Zhang, Yanjun
    RSC ADVANCES, 2018, 8 (09) : 4937 - 4945
  • [37] Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target
    Voorde, Johan Vande
    Steven, Rory T.
    Najumudeen, Arafath K.
    Ford, Catriona A.
    Dexter, Alex
    Gonzalez-Fernandez, Ariadna
    Nikula, Chelsea J.
    Xiang, Yuchen
    Ford, Lauren
    Stavrakaki, Stefania Maneta
    Gilroy, Kathryn
    Zeiger, Lucas B.
    Pennel, Kathryn
    Hatthakarnkul, Phimmada
    Elia, Efstathios A.
    Nasif, Ammar
    Murta, Teresa
    Manoli, Eftychios
    Mason, Sam
    Gillespie, Michael
    Lannagan, Tamsin R. M.
    Vlahov, Nikola
    Ridgway, Rachel A.
    Nixon, Colin
    Raven, Alexander
    Mills, Megan
    Athineos, Dimitris
    Kanellos, Georgios
    Nourse, Craig
    Gay, David M.
    Hughes, Mark
    Burton, Amy
    Yan, Bin
    Sellers, Katherine
    Wu, Vincen
    De Ridder, Kobe
    Shokry, Engy
    Uribe, Alejandro Huerta
    Clark, William
    Clark, Graeme
    Kirschner, Kristina
    Thienpont, Bernard
    Li, Vivian S. W.
    Maddocks, Oliver D. K.
    Barry, Simon T.
    Goodwin, Richard J. A.
    Kinross, James
    Edwards, Joanne
    Yuneva, Mariia O.
    Sumpton, David
    NATURE METABOLISM, 2023, 5 (08) : 1303 - +
  • [38] Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance
    Ricciardelli, Carmela
    Lokman, Noor A.
    Pyragius, Carmen E.
    Ween, Miranda P.
    Macpherson, Anne M.
    Ruszkiewicz, Andrew
    Hoffmann, Peter
    Oehler, Martin K.
    ONCOTARGET, 2017, 8 (11) : 17819 - 17832
  • [39] Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: Clinical considerations
    Ferrandina, Gabriella
    Legge, Francesco
    Salutari, Vanda
    Paglia, Amelia
    Testa, Antonia
    Scambia, Giovanni
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (14) : 2296 - 2302
  • [40] Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer
    Tang, Liangdan
    Yang, Junzheng
    Ng, Shu-Kay
    Rodriguez, Noah
    Choi, Pui-Wah
    Vitonis, Allison
    Wang, Kui
    McLachlan, Geoffrey J.
    Caiazzo, Robert J., Jr.
    Liu, Brian C. -S.
    Welch, William R.
    Cramer, Daniel W.
    Berkowitz, Ross S.
    Ng, Shu-Wing
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (01) : 170 - 179
12345